TY - JOUR
AU - Alexander, James L.
AU - Kennedy, Nicholas A.
AU - Ibraheim, Hajir
AU - Anandabaskaran, Sulak
AU - Saifuddin, Aamir
AU - Castro Seoane, Rocio
AU - Liu, Zhigang
AU - Nice, Rachel
AU - Bewshea, Claire
AU - D'Mello, Andrea
AU - Constable, Laura
AU - Jones, Gareth
AU - Balarajah, Sharmili
AU - Fiorentino, Francesca
AU - Sebastian, Shaji
AU - Irving, Peter M
AU - Hicks, Lucy C.
AU - Williams, Horace R.T.
AU - Kent, Alexandra J.
AU - Linger, Rachel
AU - Parkes, Miles
AU - Kok, Klaartje B.
AU - Patel, Kamal
AU - Teare, Julian P.
AU - Altmann, Daniel M.
AU - Boyton, Rosemary J.
AU - Goodhand, James R.
AU - Hart, Ailsa
AU - Lees, Charlie W
AU - Ahmad, Tariq
AU - Powell, Nick
PY - 2022
DA - April
TI - COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
JO - The Lancet Gastroenterology & Hepatology
EP - 352
VL - 7
IS - 4
DO - https://doi.org/10.1016/S2468-1253(22)00005-X
AB - BACKGROUND: The effects that therapies for inflammatory bowel disease (IBD) have on immune responses to SARS-CoV-2 vaccination are not yet fully known. Therefore, we sought to determine whether COVID-19 vaccine-induced antibody responses were altered in patients with IBD on commonly used immunosuppressive drugs.
PB - Elsevier
UR - https://www.research.ed.ac.uk/en/publications/f00fb3d9-4010-4726-a5be-784cd6047162
KW - Coronavirus (COVID-19)
KW - Immunisation and screening
ER